Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nicole LaRue"'
Autor:
Maria Kahn, Nicole LaRue, Changcheng Zhu, Sampa Pal, Jack S Mo, Lynn K Barrett, Steve N Hewitt, Mitchell Dumais, Sandra Hemmington, Adrian Walker, Jeff Joynson, Brandon T Leader, Wesley C Van Voorhis, Gonzalo J Domingo
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177885 (2017)
BACKGROUND:A large gap for the support of point-of-care testing is the availability of reagents to support quality control (QC) of diagnostic assays along the supply chain from the manufacturer to the end user. While reagents and systems exist to sup
Externí odkaz:
https://doaj.org/article/49c9d63f5be84fd0aecf03f8cea44b5a
Publikováno v:
Journal of Histochemistry & Cytochemistry. 63:454-458
Cytochemical staining remains an efficient way of identifying females who are heterozygous for the X chromosome-linked glucose-6-phosphate dehydrogenase ( G6PD) gene. G6PD is highly polymorphic with certain alleles resulting in low intracellular G6PD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2674dc81b6f0166ee8ef3ac7ffcdcc5d
https://doi.org/10.1369/0022155415580594
https://doi.org/10.1369/0022155415580594
Autor:
Marjorie Murray, Pooja Bansil, Maria Kahn, Hao Zhang, Sarah McGray, Michael Kalnoky, Gonzalo J. Domingo, Nicole LaRue, Hui Jiang, Brandon T. Leader, Huiqiang Huang
Publikováno v:
The American Journal of Tropical Medicine and Hygiene
A barrier to eliminating Plasmodium vivax malaria is inadequate treatment of infected patients. 8-Aminoquinoline–based drugs clear the parasite; however, people with glucose-6-phosphate dehydrogenase (G6PD) deficiency are at risk for hemolysis from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec59398878a13084c35c326a1c99d731
https://doi.org/10.4269/ajtmh.14-0194
https://doi.org/10.4269/ajtmh.14-0194
Autor:
François Nosten, Brandon T. Leader, Gonzalo J. Domingo, Nicole LaRue, Germana Bancone, Sampa Pal, Maria Kahn, Michael Kalnoky
Publikováno v:
Malaria Journal
8-aminoquinoline drugs are critical to malaria elimination campaigns due to their unique ability to kill the dormant liver stage form of Plasmodium vivax. Due to the potential for hemolytic reactions in G6PD-deficient patients, safe administration of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0b54e78ed11785781f0d6305dbafa22
https://doi.org/10.1186/1475-2875-13-s1-p48
https://doi.org/10.1186/1475-2875-13-s1-p48
Publikováno v:
Malaria Journal
Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common human enzyme deficiency. It is characterized by abnormally low levels of G6PD activity. Individuals with G6PD deficiency are at risk of undergoing acute haemolysis when expose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da32ac3ea94c79842927da62885f50ad
https://doi.org/10.1186/1475-2875-12-286
https://doi.org/10.1186/1475-2875-12-286
Autor:
Gonzalo J. Domingo, Nicole LaRue, Allison Golden, Tala de los Santos, Joseph Kubofcik, Cathy Steel, Thomas B. Nutman
The Global Programme to Eliminate Lymphatic Filariasis has an urgent need for rapid assays to detect ongoing transmission of lymphatic filariasis (LF) following multiple rounds of mass drug administration (MDA). Current WHO guidelines support using t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::448fe0c68cfa51c2ef691a4523311a3a
https://europepmc.org/articles/PMC3754496/
https://europepmc.org/articles/PMC3754496/
Publikováno v:
Malaria Journal
Glucose-6-phosphate dehydrogenase (G6PD) deficiency tests play a critical role in supporting the safe treatment and elimination of malaria. Evaluating G6PD activity in those infected with Plasmodium vivax will be essential in order to treat and achie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::575e1e3053b7afc93f05555d7857ec02
http://europepmc.org/articles/PMC4179213
http://europepmc.org/articles/PMC4179213